Remdesivir 1st Covid-19 Treatment Recommended for EU Authorization

Gilead Sciences Inc.’s remdesivir has been endorsed as the first treatment of Covid-19 in the European Union.

The European Medicines Agency said Thursday that it has recommended granting a conditional marketing authorization in the bloc to the antiviral drug for the treatment of coronavirus in patients aged 12 and older who have pneumonia and require supplemental oxygen.

The European Commission now has to grant a decision on the EMA’s recommendation. It aims to do so in the coming week, allowing the product to be marketed in the EU, the EMA said.

https://www.marketscreener.com/GILEAD-SCIENCES-INC-4876/news/Gilead-Sciences-Remdesivir-Becomes-First-Covid-19-Treatment-Recommended-for-EU-Authorization-30824570/